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In recent years, the frequency of cholera epidemics across Africa has increased signiﬁcantly with thou-
sands of people dying each year. However, there still exists a lack of information concerning the Vibrio
cholerae O1 lineages driving early and contemporary epidemics since the seventh cholera pandemic
started in the continent. This compromises the understanding of the forces determining the epidemiology
of cholera in Africa and its control. This study aimed to analyze a collection of V. cholerae O1 strains from
the beginning of the seventh cholera pandemic in Ghana and to compare them with recent isolates to
understand the evolution of the cholera epidemic in Ghana. V. cholerae O1 strains were characterized
by means of Multilocus Sequence Analysis (MLSA), genes from the virulence core genome (VCG), and
genes related to the choleragenic phenotype. Our results revealed two major clusters of Ghanaian V. chol-
erae O1 strains, El Tor and Amazonia/Ghana. Concerning the virulence genes, all strains harbored the set
of VCG and most were positive for VSP-II genomic island. The ctxB gene of the contemporary strains was
characterized as Altered El Tor. The strains from 1970 to 1980 were susceptible to all antibiotics tested,
except for the Amazonia/Ghana cluster that was resistant to aminoglycosides and carried the class 2
integron with the sat2-aadA1 arrangement. This study showed that distinct V. cholerae O1 were the deter-
minants of cholera outbreaks in Ghana. Thus, in endemic regions, such as Africa, cholera can be caused by
various V. cholerae O1 genotypes.
 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Vibrio cholerae, the causative agent of cholera, is a major patho-
gen which is responsible for outbreaks of life-threatening diarrheal
disease worldwide, particularly in developing countries. Only in
2009, the ancient disease Cholera killed nearly 4500 people in
Africa (Mintz and Guerrant, 2009). The management of cholera
outbreaks has changed little over time. Drinking water and sewage
treatment, and oral/intravenous rehydratation are the measures
applied to prevent and treat the disease. V. cholerae is phenotypi-
cally characterized by the O somatic antigen. While over 200
serogroups are currently recognized, only the O1 and O139 sero-
groups have been responsible for epidemics and pandemics of
cholera (Dharmasena et al., 2009). The pandemic V. cholerae O1 lin-do Cruz (IOC)/FIOCRUZ, Av.
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(Kaper et al., 1995). Seven cholera pandemics have been recorded,
the ﬁrst one in 1817. The sixth pandemic, and probably the earlier
ones as well, were caused by the classical V. cholerae O1 biotype.
The current seventh pandemic originated in Indonesia in 1961, is
the most extensive in geographic spread and duration, and is
caused by the El Tor biotype, which almost completely replaced
the classical biotype (Kaper et al., 1995). Several clinical V. cholerae
O1 strains cannot be classiﬁed into any of these two biotypes. Re-
cently, the term ‘atypical El Tor’ has been applied to these unusual
strains, some of which present a mix of both Classical and El Tor
traits and which at least carry the Classical ctxB allele (Safa et al.,
2010). Among the atypical El Tor strains, some lineages have been
characterized, i.e., Matlab and Mozambique variants, Altered El Tor
and Hybrid El Tor (Safa et al., 2010).
Cholera has contributed to a considerable disease burden in
Africa, particularly in the early years of the 21st century (Mintz
and Guerrant, 2009). The seventh pandemic entered Africa in
1970 by the Western countries of Guinea, Sierra Leone, Liberia,
Ghana and Nigeria and spread inland along rivers and trade routes
where it remains an ongoing source of mortality (Gaffga et al.,
2007). In 2006, the coastal West African countries reported large
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June 2006, in particular, 1869 cases and 79 deaths (4.2% fatality
rate) were reported in Ghana (Opintan et al., 2008). Studies focus-
ing on the molecular epidemiology of V. cholerae O1 in Africa are
rare, despite of the severity of epidemics and the importance of this
information in the understanding and control of this permanent
public health threat in the continent. One exception was a study
which conducted a surveillance of cholera in Beira/Mozambique
that characterized some V. cholerae O1 strains as genetic hybrids
denominated the Matlab variants (Ansaruzzaman et al., 2004).
In order to determine the population structure of choleragenic
V. cholerae O1 from Ghana, we analyzed a collection of clinical
strains isolated between 1970 and 1981, representing the begin-
ning of the seventh cholera epidemic in Africa, as well as strains
from the 2006 outbreaks. These strains were characterized by Mul-
tilocus Sequence Analysis (MLSA), using housekeeping genes, and
by macrorestriction proﬁles, for inter and intra-lineages analysis,
respectively. The following genes involved in the choleragenic phe-
notype were analyzed: the major virulence determinants (cholera
toxin (ctxAB) and toxin-coregulated pilus (tcpA)), the Vibrio sev-
enth pandemic island-II (VSP-II), and genes from the virulence core
genome (VCG) (Gu et al., 2009). The VCG genes are involved in the
hemolytic activity (hlyB), in bile acid resistance (gshB, hepA, recO
and tolC), RTX toxin (rtxA) and haemagglutinin/protease (hapA)
(Gu et al., 2009).Table 1
Phenotypic and genotypic traits of clinical V. cholerae O1 strains used in this study.
V. cholerae O1 strains Isolation Antimicrobial resistance proﬁle
0395 India, 1965 ND
LMG 21698T Asia ND
MAK757 Celebes Island, 1937 ND
N16961 Bangladesh, 1975 ND
TM 11079-80 Brazil, 1980 ND
V33 Ghana, 2006 SXT, AMP, NAL
V34 Ghana, 2006 SXT, NAL
V35 Ghana, 2006 SXT, NAL
V42 Ghana, 2006 SXT
V47 Ghana, 2006 SXT
V51 Ghana, 2006 SXT
V52 Ghana, 2006 SXT
V53 Ghana, 2006 SXT, AMP, NAL
V78 Ghana, 2006 SXT, AMP, NAL, CAZ, CRO, CHL,
V84 Ghana, 2006 SXT, AMP, TET, CXM
V90 Ghana, 2006 SXT, AMK, CAZ, CRO, CTXCHL, G
V97 Ghana, 2006 SXT
V98 Ghana, 2006 SXT, AMP
VC33 Tanzania, 1979 Susceptible
VC34 Ghana, 1970 Susceptible
VC37 Ghana, 1980 Susceptible
VC92 Ghana, 1980 STP, SPT
VC94 Ghana, 1979 STP, SPT
VC95 Ghana, 1978 STP, SPT
VC96 Ghana, 1978 STP, SXT
VC97 Ghana, 1979 STP, SPT
VC98 Ghana, 1979 STP, SPT
VC102 Ghana, 1979 STP
VC104 Algeria, 1972 STP
VC106 Ghana, 1980 Susceptible
VC107 Ghana, 1980 Susceptible
VC121 India, 1973 Susceptible
VC192 Ghana, 1980 Susceptible
VC193 Ghana, 1981 Susceptible
VC225 Ghana, 1976 Susceptible
VC355 Amazonia (Brazil), 1992 Susceptible
VC356 Amazonia (Brazil), 1991 STP, SPT
+, Positive; , negative; ND, not determined Antibiotics tested; SXT, trimethoprim/sulfa
CTX, cefotaxime; CHL, chloranphenicol; GEN, gentamicin; TET, tetracycline; NAL, nalidix
prim. CVG: Core Virulence Genome (gshB, hapA, hepA, hlyB, recO, rtxA and tolC). VSP-II: V
* (1) GenBank; (2) Opintan et al. (2008); (3) This study; (4) Sá et al. (2010).2. Materials and methods
A total of 32 clinical V. cholerae strains from cholera outbreaks
were used in this study (Table 1). The strains are from the Vibrio
culture collection of the Laboratory of Molecular Genetics of Micro-
organisms/FIOCRUZ. For MLSA the ampliﬁcation and sequencing of
the pyrH, recA and rpoA genes were performed as described previ-
ously (Thompson et al., 2005, 2008) (Table 2). The sequences were
aligned using ClustalW (Thompson et al., 1994). Phylogenetic
analyses were conducted using MEGA version 4.0 (Tamura et al.,
2007), based on the genetic distance Neighbor-Joining method
(Saitou and Nei, 1987) using concatenated sequences. Distance
estimations were obtained by Kimura two parameter model. The
reliability of the tree topology was checked by 2000 bootstrap
replications. DNA macrorestriction proﬁle was obtained by using
NotI enzyme and Pulsed Field Gel Electrophoresis (PFGE) as previ-
ously described (Fonseca et al., 2006). The PFGE dendogram was
constructed using the BioNumerics software (Applied Maths, Bel-
gium). The similarity between the strains was determined using
the Dice coefﬁcient, and cluster analysis was performed using the
Unweighted Pair-Group Method with Arithmetic Mean (UPGMA).
All samples were screened for genes coding for the major
determinants of cholera disease, (ctxAB and tcpA), genes from the
virulence core genome of the epidemic V. cholerae O1 (gshB, hapA,
hepA, hlyB, recO, rtxA and tolC) and VSP-II (Vibrio seventhSXT/class 2 integron CVG/ctx B/tcpA gene VSP-II Reference*
/ +/+/+ / (1)
ND ND ND (1)
/ +/+/+ / (1)
/ +/+/+ +/+ (1)
/ +// / (1)
+/ +/+/ND ND (2,3)
+/+ +/+/ND ND (2,3)
+/+ +/+/ND ND (2,3)
+/+ +/+/ND ND (2,3)
+/+ +/+/ND ND (2,3)
+/+ +/+/ND ND (2,3)
+/+ +/+/ND ND (2,3)
+/+ +/+/ND ND (2,3)
CXM +/+ +/+/ND ND (2,3)
+/+ +/+/ND ND (2,3)
EN +/+ +/+/ND ND (2,3)
/+ +/+/ND ND (2,3)
+/+ +/+/ND ND (2,3)
/ +/+/+ +/+ (3)
/ +/+/+ +/+ (3)
/ +//+ / (3)
/+ +// / (3)
/+ +// / (3)
/+ +// / (3)
/ +/+/+ +/+ (3)
/+ +// / (3)
/+ +// / (3)
/ +//+ +/+ (3)
/ +//+ +/+ (3)
/ +/+/+ +/+ (3)
/ +/+/+ +/+ (3)
/ +/+/+ +/+ (3)
/ +/+/+ +/+ (3)
/ +//+ +/+ (3)
/ +/+/+ +/+ (3)
/ +// ND (3)
/+ +// ND (3,4)
methoxazole; AMK, amikacin; AMP, ampicillin; CAZ, ceftazidime; CRO, ceftriaxone;
ic acid; CXM, cefuroxime; STP, streptomycin; SPT, spectinomycin; TRM, trimetho-
ibrio seventh pandemic island-II (VC0511–VC0513).
Table 2
Primers used in this study.
Primer name Primer sequence Target region Reference
pyrH-04-F ATGASNACBAAYCCWAAACC pyrH Ansaruzzaman et al. (2004) and Thompson et al. (2008)
pyrH-02-R GTRAABGCNGMYARRTCCA
recA-01-F TGARAARCARTTYGGTAAAGG recA Ansaruzzaman et al. (2004) and Thompson et al. (2008)
recA-02-R TCRCCNTTRTAGCTRTACC
rpoA-01-F ATGCAGGGTTCTGTDACAG rpoA Ansaruzzaman et al. (2004) and Thompson et al. (2008)
rpoA-03-R GHGGCCARTTTTCHARRCGC
CT8 GCAGTCAGGTGGTCTTATTGC ctxAB This study
CT10 TCCAGATATGCAATCCTCAG
TCPA1 CACGATAAGAAAACCGGTCAAGAG tcpA Keasler and Hall (1993)
TCPA2 ACCAAATGCAACGCCGAATGGAGC
GSHBF ATCTGGCACAAAGGTCTGC gshB This study
GSHBR CTCGGTATTGTGATGGACCC
HAPF TGAATACGGCAGTAACGG hapA This study
HAPR GCCACAAGAAGCATTGAC
HEPAF AGCAAATGCACATTACGCAC hepA This study
HEPAR CTTTAGCGAGGCCGATAACC
HLYBF CAAGCCTTCGCCAATAAC hlyB This study
HLYBR CCACTTTTTTCCCTTCACC
RECOF CCGCTTGCAGTTGTTCTTTG recO This study
RECOR TGCAACGCTGTTTTGTTCTG
RTXA1 TCTTTACCATCACCACCCC rtxA This study
RTXA2 ACCACCTTCACTTATACGCC
TOLCF AGACTCTCAATACGCTGCC tolC This study
TOLCR GCACGCACATCTTTAACC
INT1 F AAAACCGCCACTGCGCCGTTA Class 1 integrase gene Fonseca et al. (2005)
INT1 R GAAGACGGCTGCACTGAACG
INT2 F GCGTTTTATGTCTAACAGTCC Class 2 integrase gene Fonseca et al. (2005)
INT2 R AAGTAGCATCAGTCCATCC
INF GGCATCCAAGCAGCAAGC Class 1 integron variable region Lévesque et al. (1995)
INB AAGCAGACTTGACCTGAT
INF2 TGGGTGAGATAATGTGCATC Class 2 integron variable region Sá et al. (2010)
INB2 TCGAGAGAGGATATGGAAGG
SXTF TCGGGTATCGCCCAAGGGCA SXT This study
SXTR GCGAAGATCATGCATAGACC
VC0511F1 CTTGCTGCGTACTTAGCA VC0511 Nusrin et al. (2009)
VC0511R1 AGTAGCATCGCTCTCGTA
VC0513F1 CTGAGGTGTTATATGTTTCG VC0513 Nusrin et al. (2009)
VC0513R1 TCAAATTTCCTGACAGTTCC
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Antimicrobial susceptibility testing was performed according to
the disc diffusion method described by the CLSI guidelines using
cephalothin, cefoxitin, nalidixic acid, ampicillin, sulfamethoxa-
zole–trimethoprim, sulfonamide, chloramphenicol, gentamicin,
tetracycline, ceftriaxone, streptomycin, and spectinomycin. The
strains were screened for the presence of integrons and their var-
iable regions. PCR reactions were performed using primers target-
ing the intI1, intI2 and intI3 genes (Fonseca et al., 2005) and the SXT
(sulfamethoxazole–trimethoprim element) (Table 2).
The gene sequences have been deposited at DDBJ/EMBL/Gen-
Bank under the Accession Nos. HM003832 to HM003893.3. Results
3.1. Genetic relationship of V. cholerae O1 strains by MLSA and PFGE
The MLSA results revealed two clusters of clinical V. cholerae O1
from Ghana. One, containing the majority of the strains, belonged
to the pandemic V. cholerae O1 El Tor cluster. Strains from this clus-
ter were isolated in Ghana between 1970 and 2006 (Fig. 1 and Ta-
ble 1). The other cluster was composed of Ghanian strains VC92,
VC94, VC95, VC97 and VC98 isolated from 1978 to 1980. These
strains grouped with 100% MLSA similarity with clinical Brazilian
V. cholerae O1 Amazonia strains VC356 and VC355 isolated in
1991 and 1992, respectively, and with TM 11079-80 isolated in
1980 (Fig. 1 and Table 1). This cluster, which we called V. cholerae
O1 Amazonia/Ghana cluster, was clearly separated from theV. cholerae O1 El Tor cluster with at least 97% similarity in MLSA,
and supported by high bootstrap values (99%). The recA gene
showed the highest resolution for differentiating these two clus-
ters (3% gene sequence divergence). The PFGE dendogram (Fig. 2)
showed two major clusters, the El Tor and Amazonia/Ghana clus-
ters. The El Tor strains VC121 and VC20 (representative from the
seventh cholera pandemic) and VC34 and VC37 from Ghana
showed > 89.5% similarity. The Ghanaian strains VC92, VC94,
VC95, VC97 and VC98 were similar to the Brazilian V. cholerae O1
Amazonia strains (VC355 and VC356) (at least 91.5% similarity) de-
spite being temporally distant. The similarity between the two ma-
jor clusters is 76.2%.
These results showed the presence of a lineage shared by the
two countries however, PFGE sensitivity reveals recent genetic
diversiﬁcation within the strains from Ghana/Amazonia and El
Tor clusters.
3.2. Characterization of elements associated with antibiotic resistance
All the Ghana strains belonging to the Amazonia/Ghana cluster
were positive for class 2 integron (Table 1) as well as the V. cholerae
O1 Amazonia VC356 from the Brazilian cholera epidemic (Sá et al.,
2010). Sequence analysis of the class 2 integron gene cassette
region revealed the presence of the sat1/aadA1 array (streptothri-
cin/streptomycin and spectinomycin resistance).
All the strains isolated between 1970 and 1981, the beginning
of the pandemic in Ghana, were susceptible to all antimicrobial
agents tested (Table 1). Strains VC92, VC94, VC95, VC97 and
VC98, belonging to the Amazonia/Ghana cluster, were the
Fig. 1. Phylogenetic tree based on the Neighbor-Joining method using concatenated sequences of the pyrH, recA and rpoA housekeeping genes. Distance estimation obtained
by the Kimura two-parameter model. Bootstrap percentages after 2000 replications are shown. LMG 21698T is the type strain of V. cholerae species. V. mimicus LMG 7896T was
included as an outgroup. Bar, estimated sequence divergence. The year and origin of strain isolation are placed after the slash and hyphen, respectively.
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probably due to the presence of the aadA1 (aminoglycoside ade-
nyltransferase) gene inserted in the class 2 integrons. All strains
(1970–1981) were negative for the SXT element (SXT encodes
resistances to several antibiotics, including sulfamethoxazole and
trimethoprim (Wozniak et al., 2009)).
3.3. Detection and characterization of ctxAB and tcpA genes, VCG genes
and the VSP-II region
The two major virulence determinants, ctxAB and tcpA genes,
were not present in the strains belonging to the Amazonia/Ghana
cluster. On the other hand, most V. cholerae O1 from the El Tor clus-
ter carried these genes (Table 1). Interestingly, the ctxB gene car-
ried by the 2006 epidemic El Tor isolates from Ghana areidentical to that of the Classical biotype, characterizing an Altered
El Tor variant. The gshB, hapA, hepA, hlyB, recO, rtxA and tolC genes
that are part of the virulence core genome were present in all V.
cholerae O1 strains from the El Tor and Amazonia/Ghana lineages
(Table 1). The strains from the El Tor cluster were positive for
the presence of ORFs VC0511 and VC0513 from VSP-II genomic is-
land, except VC37. These ORFs were absent in the Amazonia/Ghana
strains.
4. Discussion
The world is under the seventh cholera pandemic since the
1960s when the El Tor lineage emerged. Cholera has continuously
emerged in places where it has been absent for a century as re-
cently occurred in Haiti in October, 2010. Variants of the pandemic
Fig. 2. Dendogram constructed from the PFGE proﬁles of representative V. cholerae strains O1. The similarity between the strains was determined using the Dice coefﬁcient,
and cluster analysis was performed using the UPGMA .
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outbreaks. Therefore, consistent surveillance programs character-
izing V. cholerae strains from the distinct outbreaks worldwide
are necessary to understand the epidemiology of the disease. In
this study, the genetic characterization of contemporary and old
V. cholerae strains causing cholera in Ghana was performed for
the ﬁrst time.
Our study revealed that, in the beginning of the seventh cholera
pandemic in Ghana, at least two V. cholerae O1 lineages, Amazonia/
Ghana and El Tor, were co-circulating causing cholera. A similar
scenario had been demonstrated in the Brazilian cholera epidemic
when the V. cholerae O1 Amazonia lineage was ﬁrst characterized
(Coelho et al., 1995). This lineage was isolated from cholera out-
breaks in northern Brazil/Amazonia (1991 and 1992), and was
proved to be distinct from the prevailing El Tor seventh pandemic
lineage (Thompson et al., In Press). So far, V. cholerae O1 Amazonia
was thought to be restricted to villages of the Amazon Basin and
was probably unable to compete with the invading El Tor lineage
(Coelho et al., 1995). However, our results clearly showed that V.
cholerae O1 Amazonia was already circulating at the beginning of
the seventh pandemic in Ghana (1978–1980). Amazonia strains
might have escaped detection owing to their low prevalence,
and/or because they share a common important phenotypic mar-
ker, the O1 antigen, used to characterize V. cholerae isolates during
cholera outbreaks (Chun et al., 2009). The occurrence of the
Amazonia/Ghana lineage in distinct times and places, Brazil/
1991–1992 and Ghana/1978–1980, indicates its ability in spread-
ing, ﬁtness, and epidemic potential.
Chin et al. (2011) corroborates the Lam et al. (2010) hypothesis
that the V. cholerae O1 strains from the Latin American cholera epi-
demic were introduced from Africa, as opposed to the previous
hypothesis suggesting their origin in Asia. The authors argue that
the mass migration from Africa to South America in the 1970s
brought V. cholerae into the region. Our ﬁndings, showing the pres-
ence of strains belonging to the Amazonia/Ghana cluster in Ghana
(1978–1980), support the Africa to South America route in the epi-
demiology of the seventh cholera pandemic.
The presence of class 2 integron in strains of Amazonia/Ghana
lineage but not in the El Tor strains, at the beginning of seventh
cholera pandemic in Ghana, contrast with results from Opintan
et al. (2008). The authors showed that most of V. cholerae O1 El
Tor strains from the 2006 cholera outbreak in Ghana carried class
2 integron, which is a rare trait in V. cholerae O1. All together theseﬁndings suggest that this element was horizontally transferred
from the Amazonia/Ghana lineage to El Tor, in the course of the
epidemics in the country. The current class 2 integron carries the
canonical dfrA1, sat and aadA1 array while the class 2 integron of
the Amazonia/Ghana strains, from 1970 to 1980, lacked dfrA1.
The evolution of this variable region can be due to the acquisition
of dfrA1, by in trans activity mediated by intVchA, from the chro-
mosomal integron (Ahmed et al., 2006).
Recently, several works demonstrated the emergence of El Tor
strains encoding the classical cholera toxin causing epidemics in
Asian and African countries (Safa et al., 2010). In some of these out-
breaks, due to these Altered El Tor strains, a much higher propor-
tion of patients presenting severe dehydration was noticed. So
far, in Africa, these Altered El Tor strains have been described in
Mozambique and Zambia (Safa et al., 2010) as successful clinical
clones and as having replaced the prototypical O1 El Tor (Grim
et al., 2010). We demonstrated the occurrence of the Altered V.
cholerae O1 strains in the Ghana outbreak for the ﬁrst time.
Opintan et al. (2008) showed that Ghana strains from 2006
were resistant to multiple antibiotics, including trimethoprim/
sulfamethoxazole, that is associated with the presence of the
SXT element, presented in the strains. These results, together
with our ﬁndings related to the susceptibility of the isolates from
the beginning of the 7th pandemic, showed that V. cholerae O1
antibiotic resistance has been evolving during the cholera pan-
demic in Ghana. Concerning the emergence of the SXT element,
it was showed that Altered V. cholerae O1 strains are carrying this
element, as was also recently observed in India (Goel and Jiang,
2010).
Studies on the molecular epidemiology of V. cholerae O1 are of
extreme importance to better understand the dynamics of this
bacterium in epidemics and pandemics of cholera, and for the
implementation of control measures. The work applying genomic
analysis to determine the origin of the Haitian cholera outbreak
strain is a landmark in this ﬁeld (Chin et al., 2011). Our work dem-
onstrated that in endemic regions, such as Africa, several
genotypes could be driving cholera outbreaks.
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